Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-27

Clinical Trial Update: Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effect of Bifidobacterium animalis subsp. lactis HN019 on oral lichen planus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bifidobacterium animalis subsp. lactis HN019 (Bifidobacterium animalis subsp. lactis HN019)

Snippet

Sponsor: University of Sao Paulo | Conditions: Oral Lichen Planus | Phase 2 | Status: COMPLETED